163 related articles for article (PubMed ID: 11467769)
1. Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.
Lee NC; Bouvet M; Nardin S; Jiang P; Baranov E; Rashidi B; Yang M; Wang X; Moossa AR; Hoffma RM
Clin Exp Metastasis; 2000; 18(5):379-84. PubMed ID: 11467769
[TBL] [Abstract][Full Text] [Related]
2. Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Zhang Z; Park JH; Kawaguchi K; Chawla SP; Bouvet M; Singh SR; Unno M; Hoffman RM
Anticancer Res; 2019 Oct; 39(10):5339-5344. PubMed ID: 31570427
[TBL] [Abstract][Full Text] [Related]
3. Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine.
Amoh Y; Li L; Tsuji K; Moossa AR; Katsuoka K; Hoffman RM; Bouvet M
J Surg Res; 2006 May; 132(2):164-9. PubMed ID: 16500746
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model.
Sun FX; Tohgo A; Bouvet M; Yagi S; Nassirpour R; Moossa AR; Hoffman RM
Cancer Res; 2003 Jan; 63(1):80-5. PubMed ID: 12517781
[TBL] [Abstract][Full Text] [Related]
5. Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer.
Amoh Y; Nagakura C; Maitra A; Moossa AR; Katsuoka K; Hoffman RM; Bouvet M
Anticancer Res; 2006; 26(5A):3237-42. PubMed ID: 17094435
[TBL] [Abstract][Full Text] [Related]
6. Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: a comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice.
Egberts JH; Schniewind B; Sipos B; Hinz S; Kalthoff H; Tepel J
Cancer Biol Ther; 2007 Aug; 6(8):1227-32. PubMed ID: 17700058
[TBL] [Abstract][Full Text] [Related]
7. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.
Tran Cao HS; Bouvet M; Kaushal S; Keleman A; Romney E; Kim G; Fruehauf J; Imagawa DK; Hoffman RM; Katz MH
Mol Cancer Ther; 2010 Jul; 9(7):2068-78. PubMed ID: 20606044
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
[TBL] [Abstract][Full Text] [Related]
10. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
[TBL] [Abstract][Full Text] [Related]
11. The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer.
Kurosaki I; Hatakeyama K
Hepatogastroenterology; 2004; 51(57):634-7. PubMed ID: 15143880
[TBL] [Abstract][Full Text] [Related]
12. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.
Takano S; Togawa A; Yoshitomi H; Shida T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Tomonaga T; Nomura F; Miyazaki M
Ann Surg Oncol; 2008 Nov; 15(11):3157-68. PubMed ID: 18712570
[TBL] [Abstract][Full Text] [Related]
13. Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells.
Gürlevik E; Fleischmann-Mundt B; Brooks J; Demir IE; Steiger K; Ribback S; Yevsa T; Woller N; Kloos A; Ostroumov D; Armbrecht N; Manns MP; Dombrowski F; Saborowski M; Kleine M; Wirth TC; Oettle H; Ceyhan GO; Esposito I; Calvisi DF; Kubicka S; Kühnel F
Gastroenterology; 2016 Aug; 151(2):338-350.e7. PubMed ID: 27210037
[TBL] [Abstract][Full Text] [Related]
14. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
Bruns CJ; Shrader M; Harbison MT; Portera C; Solorzano CC; Jauch KW; Hicklin DJ; Radinsky R; Ellis LM
Int J Cancer; 2002 Nov; 102(2):101-8. PubMed ID: 12385004
[TBL] [Abstract][Full Text] [Related]
15. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.
García-Santos EP; Padilla-Valverde D; Villarejo-Campos P; Murillo-Lázaro C; Fernández-Grande E; Palomino-Muñoz T; Rodríguez-Martínez M; Amo-Salas M; Nuñez-Guerrero P; Sánchez-García S; Puerto-Puerto A; Martín-Fernández J
Pancreatology; 2016; 16(4):632-9. PubMed ID: 27289344
[TBL] [Abstract][Full Text] [Related]
16. LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.
Hennig R; Ventura J; Segersvard R; Ward E; Ding XZ; Rao SM; Jovanovic BD; Iwamura T; Talamonti MS; Bell RH; Adrian TE
Neoplasia; 2005 Apr; 7(4):417-25. PubMed ID: 15967119
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model.
Tepel J; Kruse ML; Kapischke M; Haye S; Sipos B; Kremer B; Kalthoff H
Pancreatology; 2006; 6(3):240-7. PubMed ID: 16543775
[TBL] [Abstract][Full Text] [Related]
18. Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.
Chen L; Zhou D; Liu Z; Huang X; Liu Q; Kang Y; Chen Z; Guo Y; Zhu H; Sun C
Oncol Rep; 2018 Mar; 39(3):1081-1089. PubMed ID: 29328487
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
20. Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.
Ozkok S; Demirci S; Yalman D; Zeytunlu M; Nart D; Yuzer Y; Coker A; Goker E
Tumori; 2010; 96(4):560-7. PubMed ID: 20968135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]